loading
Schlusskurs vom Vortag:
$29.52
Offen:
$29.22
24-Stunden-Volumen:
43,457
Relative Volume:
0.10
Marktkapitalisierung:
$1.29B
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+0.31%
1M Leistung:
+24.00%
6M Leistung:
+197.67%
1J Leistung:
+0.00%
1-Tages-Spanne:
Value
$28.98
$30.26
1-Wochen-Bereich:
Value
$27.54
$31.93
52-Wochen-Spanne:
Value
$6.71
$31.93

Maze Therapeutics Inc Stock (MAZE) Company Profile

Name
Firmenname
Maze Therapeutics Inc
Name
Telefon
(650) 850-5070
Name
Adresse
171 OYSTER POINT BOULEVARD, SUITE 300, SOUTH SAN FRANCISCO
Name
Mitarbeiter
125
Name
Twitter
Name
Nächster Verdiensttermin
Name
Neueste SEC-Einreichungen
Name
MAZE's Discussions on Twitter

Vergleichen Sie MAZE mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
MAZE
Maze Therapeutics Inc
29.40 1.43B 0 0 0 0.00
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
428.83 107.45B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
468.37 64.39B 2.46B -319.09M -52.09M -2.4669
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
585.75 61.13B 14.21B 4.46B 3.56B 39.69
Biotechnology icon
ARGX
Argen X Se Adr
828.00 52.30B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
ONC
Beone Medicines Ltd Adr
314.16 34.99B 4.56B -176.77M 225.30M -1.7177

Maze Therapeutics Inc Stock (MAZE) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-09-02 Eingeleitet BTIG Research Buy
2025-07-23 Eingeleitet H.C. Wainwright Buy
2025-07-08 Eingeleitet Wedbush Outperform

Maze Therapeutics Inc Aktie (MAZE) Neueste Nachrichten

pulisher
Oct 21, 2025

Maze Therapeutics Inc. recovery potential after sell offPortfolio Risk Summary & Fast Entry Momentum Alerts - newser.com

Oct 21, 2025
pulisher
Oct 21, 2025

Pattern recognition hints at Maze Therapeutics Inc. upsideWeekly Trade Review & Long-Term Safe Investment Plans - newser.com

Oct 21, 2025
pulisher
Oct 21, 2025

Does Maze Therapeutics Inc. qualify in momentum factor screeningNew Guidance & Verified Momentum Stock Watchlist - newser.com

Oct 21, 2025
pulisher
Oct 20, 2025

Developing predictive dashboards with Maze Therapeutics Inc. dataJuly 2025 Opening Moves & Advanced Technical Signal Analysis - newser.com

Oct 20, 2025
pulisher
Oct 20, 2025

Will Maze Therapeutics Inc. outperform the marketPortfolio Update Report & Verified Momentum Watchlists - newser.com

Oct 20, 2025
pulisher
Oct 20, 2025

What is the fair value of Maze Therapeutics Inc. stock nowJuly 2025 Levels & Precise Buy Zone Identification - newser.com

Oct 20, 2025
pulisher
Oct 20, 2025

Can Maze Therapeutics Inc. stock beat market expectations this quarterPortfolio Profit Report & Real-Time Buy Zone Alerts - newser.com

Oct 20, 2025
pulisher
Oct 19, 2025

Why Maze Therapeutics Inc. is moving todayWeekly Profit Recap & Verified High Yield Trade Plans - newser.com

Oct 19, 2025
pulisher
Oct 18, 2025

Can Maze Therapeutics Inc. stock deliver sustainable ROEJuly 2025 Action & Real-Time Stock Price Movement Reports - nchmf.gov.vn

Oct 18, 2025
pulisher
Oct 18, 2025

Is Maze Therapeutics Inc. stock a top momentum playTrade Exit Summary & Community Consensus Stock Picks - nchmf.gov.vn

Oct 18, 2025
pulisher
Oct 18, 2025

Will Maze Therapeutics Inc. stock rally after Fed decisionsQuarterly Market Review & Technical Entry and Exit Alerts - nchmf.gov.vn

Oct 18, 2025
pulisher
Oct 18, 2025

What drives Maze Therapeutics Inc stock priceDividend Growth Stocks & Analyze Your Portfolio Risk in Seconds - earlytimes.in

Oct 18, 2025
pulisher
Oct 18, 2025

Portfolio Update: Will Maze Therapeutics Inc. stock benefit from AI adoptionMarket Volume Report & Verified Momentum Watchlists - nchmf.gov.vn

Oct 18, 2025
pulisher
Oct 18, 2025

Will Maze Therapeutics Inc. stock benefit from AI adoptionPortfolio Return Summary & Verified Chart Pattern Signals - nchmf.gov.vn

Oct 18, 2025
pulisher
Oct 11, 2025

ETFs Investing in Maze Therapeutics, Inc. Stocks - TradingView

Oct 11, 2025
pulisher
Oct 10, 2025

Weiss Ratings Reaffirms "Sell (D)" Rating for Maze Therapeutics (NASDAQ:MAZE) - MarketBeat

Oct 10, 2025
pulisher
Oct 10, 2025

Can a trend reversal in Maze Therapeutics Inc. lead to recovery2025 Fundamental Recap & Capital Protection Trade Alerts - newser.com

Oct 10, 2025
pulisher
Oct 09, 2025

How to use a screener to detect Maze Therapeutics Inc. breakoutsWall Street Watch & Free Daily Entry Point Trade Alerts - newser.com

Oct 09, 2025
pulisher
Oct 06, 2025

Pompe Disease Market Research 2025: Treatment, Route of Administration, and Region Analysis and Forecast to 2035 Featuring Amicus Therapeutics, Astellas, BioMarin, Maze Therapeutics, Oxyrane ParasailResearchAndMarkets.com - The AI Journal

Oct 06, 2025
pulisher
Oct 06, 2025

Maze Therapeutics (NASDAQ:MAZE) Reaches New 1-Year HighWhat's Next? - MarketBeat

Oct 06, 2025
pulisher
Oct 06, 2025

Maze Therapeutics Appoints Herve Hoppenot as Board Chairman - MarketScreener

Oct 06, 2025
pulisher
Oct 06, 2025

What technical models suggest about Maze Therapeutics Inc.’s comeback2025 Major Catalysts & Long Hold Capital Preservation Plans - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

Maze Therapeutics appoints Hervé Hoppenot as chairman of the board - Investing.com

Oct 06, 2025
pulisher
Oct 06, 2025

Maze Therapeutics Appoints Hervé Hoppenot as Chairman - TipRanks

Oct 06, 2025
pulisher
Oct 06, 2025

Maze Therapeutics appoints Hervé Hoppenot as board chairman - Investing.com India

Oct 06, 2025
pulisher
Oct 06, 2025

Maze Therapeutics appoints Hervé Hoppenot as board chairman By Investing.com - Investing.com Australia

Oct 06, 2025
pulisher
Oct 06, 2025

Maze Therapeutics Appoints Industry Veteran Hervé Hoppenot as Chairman of the Board of Directors - GlobeNewswire

Oct 06, 2025
pulisher
Oct 06, 2025

Detecting price anomalies in Maze Therapeutics Inc. with AI2025 Sector Review & Growth Focused Stock Pick Reports - newser.com

Oct 06, 2025
pulisher
Oct 05, 2025

Predicting Maze Therapeutics Inc. trend using moving averages2025 Top Decliners & Verified Swing Trading Watchlist - newser.com

Oct 05, 2025
pulisher
Oct 04, 2025

Maze Therapeutics (MAZE): Assessing Current Valuation Following a 78% Monthly Share Price Surge - Sahm

Oct 04, 2025
pulisher
Oct 04, 2025

Maze Therapeutics (MAZE): Assessing Valuation After 78% 30-Day Share Price Surge - Yahoo Finance

Oct 04, 2025

Finanzdaten der Maze Therapeutics Inc-Aktie (MAZE)

Es liegen keine Finanzdaten für Maze Therapeutics Inc (MAZE) vor. Überprüfen Sie andere Aktien für weitere Informationen.

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$37.49
price up icon 0.05%
$87.86
price up icon 0.73%
$29.92
price down icon 0.40%
$105.92
price down icon 1.08%
$161.26
price down icon 2.47%
biotechnology ONC
$314.48
price down icon 0.28%
Kapitalisierung:     |  Volumen (24h):